Q1 2027 Mesa Laboratories Inc Earnings Call Transcript
Key Points
- Mesa Laboratories Inc (MLAB) returned to positive core organic revenue growth in Q1, with BPD growing 5% and Calibration Solutions growing 7.6% year-over-year.
- Adjusted operating income (excluding unusual items) increased nearly 20% in the quarter, with margin expansion of roughly 390 basis points year-over-year.
- The company made significant progress on its balance sheet, paying down $8.7 million of debt and reducing net leverage to 1.85x, with a target of 1.5x-1.75x by fiscal year-end.
- SDC's underlying demand remains healthy, with trailing 12-month revenue up about 5% year-over-year, and the company is actively addressing delivery reliability issues.
- Management is prioritizing self-help and execution, including accelerating the next-generation Gyrolab platform launch to fiscal 2028, signaling a focus on organic growth.
- SDC reported organic revenue declined 3.6% year-over-year due to delivery reliability issues, with past due backlog rising by about $1 million from its year-end low.
- The company acknowledged that improvements in SDC's backlog were episodic rather than durable, and it is still working to convert surge work into standard work.
- BPD's 5% growth was partly attributed to easier comparisons and catch-up orders, and the turnaround is not yet complete, with commercial rebuilding expected to take most of a year.
- Clinical Genomics remained flat, with China declining 7%, and the company is managing this business deliberately but not expecting a quick recovery.
- GAAP net income decreased 40.3% due to non-operating currency swings, and the company cautioned against annualizing Q1's strong margin performance.
Good afternoon and thank you for joining us to discuss Mesa Laboratories First Quarter 2027 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded. Speakers today are Siddhartha Kadia, President and Chief Executive Officer; John Sakys, Vice President and Chief Financial Officer; and Doug Farrell, Investor Relations.
It is now my pleasure to introduce Doug Farrell. Mr. Farrell, you may begin.
Thank you, Jen. Please be advised that our remarks today, including answers to your questions, include forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Forward-looking statements include those relating to future financial and operational results, future taxes, future strategic and operational initiatives, new products, and our future net leverage ratio. Words such as seek, expect, plan, intend, anticipate, believe, could, should, estimate, may, project, and target, and similar expressions may also identify forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
